Bitter-sweet symphony: glycan–lectin interactions in virus biology

Abstract Glycans are carbohydrate modifications typically found on proteins or lipids, and can act as ligands for glycan-binding proteins called lectins. Glycans and lectins play crucial roles in the function of cells and organs, and in the immune system of animals and humans. Viral pathogens use glycans and lectins that are encoded by their own or the host genome for their replication and spread. Recent advances in glycobiological research indicate that glycans and lectins mediate key interactions at the virus-host interface, controlling viral spread and/or activation of the immune system. This review reflects on glycan–lectin interactions in the context of viral infection and antiviral immunity. A short introduction illustrates the nature of glycans and lectins, and conveys the basic principles of their interactions. Subsequently, examples are discussed highlighting specific glycan–lectin interactions and how they affect the progress of viral infections, either benefiting the host or the virus. Moreover, glycan and lectin variability and their potential biological consequences are discussed. Finally, the review outlines how recent advances in the glycan–lectin field might be transformed into promising new approaches to antiviral therapy.

[1]  W. Zimmermann,et al.  The Core 2 β-1,6-N-Acetylglucosaminyltransferase-Mucin Encoded by Bovine Herpesvirus 4 Was Acquired from an Ancestor of the African Buffalo , 2003, Journal of Virology.

[2]  E. Freed,et al.  Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures , 1996, Journal of virology.

[3]  S. Pöhlmann,et al.  The multiple facets of HIV attachment to dendritic cell lectins , 2010, Cellular microbiology.

[4]  H. Klenk,et al.  Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. , 1986, The Journal of biological chemistry.

[5]  S. Hawgood,et al.  Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. , 2002, American journal of respiratory cell and molecular biology.

[6]  R. Compans,et al.  Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies. , 2005, Virology.

[7]  L. Enjuanes,et al.  Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity , 1996, Journal of virology.

[8]  Robert B Sim,et al.  Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells. , 2000, Viral immunology.

[9]  E. De Clercq,et al.  Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins , 2004, Journal of Virology.

[10]  M. Malim,et al.  cis Expression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor , 2001, Journal of Virology.

[11]  S. Gringhuis,et al.  C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. , 2007, Immunity.

[12]  Li Wu,et al.  Functionally Distinct Transmission of Human Immunodeficiency Virus Type 1 Mediated by Immature and Mature Dendritic Cells , 2007, Journal of Virology.

[13]  M. Harmsen,et al.  Interactions of surfactant protein A with influenza A viruses: binding and neutralization. , 1995, The Journal of infectious diseases.

[14]  K. Van Laethem,et al.  Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use , 2010, Antimicrobial Agents and Chemotherapy.

[15]  M. Ouellet,et al.  Glycans, galectins, and HIV‐1 infection , 2012, Annals of the New York Academy of Sciences.

[16]  O. Spiller,et al.  The relevance of complement to virus biology , 2004, Virology.

[17]  Xi Jiang,et al.  Norovirus and Histo-Blood Group Antigens: Demonstration of a Wide Spectrum of Strain Specificities and Classification of Two Major Binding Groups among Multiple Binding Patterns , 2005, Journal of Virology.

[18]  K. Hartshorn,et al.  Porcine surfactant protein D is N-glycosylated in its carbohydrate recognition domain and is assembled into differently charged oligomers. , 2002, American journal of respiratory cell and molecular biology.

[19]  B. Benaissa-Trouw,et al.  Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages , 1997, European journal of immunology.

[20]  K. Zaner,et al.  Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. , 2000, The Biochemical journal.

[21]  J. Whitsett,et al.  Correction of Pulmonary Abnormalities in Sftpd-/- Mice Requires the Collagenous Domain of Surfactant Protein D* , 2006, Journal of Biological Chemistry.

[22]  M. Jiang,et al.  Glycosphingolipids as Receptors for Non-Enveloped Viruses , 2010, Viruses.

[23]  J. Garcia-Vallejo,et al.  Endogenous ligands for C‐type lectin receptors: the true regulators of immune homeostasis , 2009, Immunological reviews.

[24]  R. Doms,et al.  Diversity of receptors binding HIV on dendritic cell subsets , 2002, Nature Immunology.

[25]  J. Jensenius,et al.  Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. , 1996, Blood.

[26]  S. Mummidi,et al.  Extensive Repertoire of Membrane-bound and Soluble Dendritic Cell-specific ICAM-3-grabbing Nonintegrin 1 (DC-SIGN1) and DC-SIGN2 Isoforms , 2001, The Journal of Biological Chemistry.

[27]  Andrew Rambaut,et al.  Pacing a small cage: mutation and RNA viruses , 2008, Trends in Ecology & Evolution.

[28]  R. Kannagi,et al.  Transactivation of the fucosyltransferase VII gene by human T-cell leukemia virus type 1 Tax through a variant cAMP-responsive element. , 2003, Blood.

[29]  J. Le Pendu,et al.  Binding of Rabbit Hemorrhagic Disease Virus to Antigens of the ABH Histo-Blood Group Family , 2000, Journal of Virology.

[30]  Jianpeng Ma,et al.  Structural basis for receptor specificity of influenza B virus hemagglutinin , 2007, Proceedings of the National Academy of Sciences.

[31]  Barbara Imperiali,et al.  The expanding horizons of asparagine-linked glycosylation. , 2011, Biochemistry.

[32]  M. Tate,et al.  Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice , 2009, Respiratory research.

[33]  J. Goedert,et al.  Association of DC-SIGN Promoter Polymorphism with Increased Risk for Parenteral, but Not Mucosal, Acquisition of Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[34]  R. Dwek,et al.  Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections , 2002, Journal of Virology.

[35]  K. Tomer,et al.  Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. , 2000, Biochemistry.

[36]  W. Greene,et al.  In Vitro Derived Dendritic Cells trans-Infect CD4 T Cells Primarily with Surface-Bound HIV-1 Virions , 2007, PLoS pathogens.

[37]  Raul Andino,et al.  Quasispecies Theory and the Behavior of RNA Viruses , 2010, PLoS pathogens.

[38]  S. Subramaniam,et al.  HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. , 2011, Blood.

[39]  D. McDonald,et al.  Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions , 2003, Science.

[40]  P. Lozach,et al.  Infection of Dendritic Cells (DCs), Not DC-SIGN-Mediated Internalization of Human Immunodeficiency Virus, Is Required for Long-Term Transfer of Virus to T Cells , 2006, Journal of Virology.

[41]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[42]  S. Maurer-Stroh,et al.  Addition of Glycosylation to Influenza A Virus Hemagglutinin Modulates Antibody-Mediated Recognition of H1N1 2009 Pandemic Viruses , 2013, The Journal of Immunology.

[43]  T. Tumpey,et al.  N-Linked Glycosylation of the Hemagglutinin Protein Influences Virulence and Antigenicity of the 1918 Pandemic and Seasonal H1N1 Influenza A Viruses , 2013, Journal of Virology.

[44]  K. Prydz,et al.  Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.

[45]  R. Hegde,et al.  Structural Basis for the Receptor Binding Specificity of Norwalk Virus , 2008, Journal of Virology.

[46]  J. Abastado,et al.  Covert Human Immunodeficiency Virus Replication in Dendritic Cells and in DC-SIGN-Expressing Cells Promotes Long-Term Transmission to Lymphocytes , 2005, Journal of Virology.

[47]  E. Soilleux,et al.  Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN+ Cells in Human Rectal Mucosa , 2005, Journal of Virology.

[48]  Fang Fang,et al.  Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein , 2009, PloS one.

[49]  J. Balzarini,et al.  Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions. , 2007, Virology.

[50]  G. Rabinovich,et al.  Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms. , 2011, International immunopharmacology.

[51]  D. Knight,et al.  Cytomegalovirus induces sialyl Lewis(x) and Lewis(x) on human endothelial cells. , 2000, Transplantation.

[52]  J. V. Van Etten,et al.  Glycosyltransferases encoded by viruses. , 2004, The Journal of general virology.

[53]  J. Balzarini,et al.  Potential of carbohydrate‐binding agents as therapeutics against enveloped viruses , 2010, Medicinal research reviews.

[54]  G. Screaton,et al.  Lectin Switching During Dengue Virus Infection , 2011, The Journal of infectious diseases.

[55]  Y. Kooyk,et al.  Protein-glycan interactions in the control of innate and adaptive immune responses , 2008, Nature Immunology.

[56]  R. Means,et al.  A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.

[57]  Steven J. Gamblin,et al.  Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins , 2010, The Journal of Biological Chemistry.

[58]  R. Dwek,et al.  Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity. , 2007, Antiviral research.

[59]  Yoshiyuki Suzuki,et al.  Evidence for N-Glycan Shielding of Antigenic Sites during Evolution of Human Influenza A Virus Hemagglutinin , 2012, Journal of Virology.

[60]  Yufei Wang,et al.  DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4 , 2011, PloS one.

[61]  J. Roth,et al.  Protein glycosylation in the endoplasmic reticulum and the Golgi apparatus and cell type-specificity of cell surface glycoconjugate expression: analysis by the protein A-gold and lectin-gold techniques , 1996, Histochemistry and Cell Biology.

[62]  S. Thiel,et al.  Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection , 2010, BMC Immunology.

[63]  W. Hendrickson,et al.  DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. , 2002, Immunity.

[64]  A. Tamanini,et al.  Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. , 2000, Virology.

[65]  A. Simmons,et al.  Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication , 2007, Nature Immunology.

[66]  G. Gaiha,et al.  Surfactant Protein D Modulates HIV Infection of Both T-Cells and Dendritic Cells , 2013, PloS one.

[67]  M. Aebi,et al.  Mechanisms and principles of N-linked protein glycosylation. , 2011, Current opinion in structural biology.

[68]  K. Ogino,et al.  RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. , 2007, AIDS research and human retroviruses.

[69]  Á. Corbí,et al.  Structural Requirements for Multimerization of the Pathogen Receptor Dendritic Cell-specific ICAM3-grabbing Non-integrin (CD209) on the Cell Surface* , 2008, Journal of Biological Chemistry.

[70]  E. Garman,et al.  Controlling influenza by inhibiting the virus's neuraminidase. , 2004, Current drug targets.

[71]  M. Wiznerowicz,et al.  Lentivirus-mediated Rna Interference of Dc-sign Expression Inhibits Human Immunodeficiency Virus Transmission from Dendritic Cells to T Cells in the Early Events of Human Immunodeficiency Virus Type 1 (hiv-1) Infection, Immature Dendritic Cells (dcs) Expressing the Dc-specific Intercellular Adhesion , 2022 .

[72]  Mark von Itzstein,et al.  Anti-influenza drugs: the development of sialidase inhibitors. , 2009, Handbook of experimental pharmacology.

[73]  E. Dittmann,et al.  Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile* , 2010, The Journal of Biological Chemistry.

[74]  Yanjun Liu,et al.  Structural Basis for the Recognition of Blood Group Trisaccharides by Norovirus , 2007, Journal of Virology.

[75]  A. Gottschalk Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae. , 1957, Biochimica et biophysica acta.

[76]  Julie Nieminen,et al.  Galectins in innate immunity: dual functions of host soluble β‐galactoside‐binding lectins as damage‐associated molecular patterns (DAMPs) and as receptors for pathogen‐associated molecular patterns (PAMPs) , 2009, Immunological reviews.

[77]  DavidE . Goldberg,et al.  Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans1 , 2006, The Journal of Immunology.

[78]  J. Whitsett,et al.  Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. , 2004, American journal of respiratory cell and molecular biology.

[79]  N. Krishna,et al.  NMR experiments reveal the molecular basis of receptor recognition by a calicivirus. , 2008, Journal of the American Chemical Society.

[80]  Kai Ludwig,et al.  Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. , 2010, Small.

[81]  R. Haag,et al.  Inhibition of Influenza Virus Activity by Multivalent Glycoarchitectures with Matched Sizes , 2011, Chembiochem : a European journal of chemical biology.

[82]  O. Larm,et al.  Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1. , 2002, Virology.

[83]  D. Littman,et al.  Dendritic Cell-Mediated trans-Enhancement of Human Immunodeficiency Virus Type 1 Infectivity Is Independent of DC-SIGN , 2006, Journal of Virology.

[84]  Benhur Lee,et al.  Identification of the Optimal DC-SIGN Binding Site on Human Immunodeficiency Virus Type 1 gp120 , 2007, Journal of Virology.

[85]  J. Lifson,et al.  Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. , 2004, Blood.

[86]  Remy Loris,et al.  Principles of structures of animal and plant lectins. , 2002, Biochimica et biophysica acta.

[87]  M. Fukuda,et al.  The core 2 beta-1,6-N-acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to post-translational modifications of structural proteins. , 2004, The Journal of general virology.

[88]  S. Thiel,et al.  Binding of human collectins (SP-A and MBP) to influenza virus. , 1994, The Biochemical journal.

[89]  Masatoshi Nei,et al.  Origin and evolution of influenza virus hemagglutinin genes. , 2002, Molecular biology and evolution.

[90]  H. Nauwynck,et al.  The M/GP5 Glycoprotein Complex of Porcine Reproductive and Respiratory Syndrome Virus Binds the Sialoadhesin Receptor in a Sialic Acid-Dependent Manner , 2010, PLoS pathogens.

[91]  T. Takeshita,et al.  Inhibition of DC‐SIGN‐mediated transmission of human immunodeficiency virus type 1 by Toll‐like receptor 3 signalling in breast milk macrophages , 2010, Immunology.

[92]  John P. Moore,et al.  Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. , 2010, Virology.

[93]  Siamon Gordon,et al.  Pattern Recognition Receptors Doubling Up for the Innate Immune Response , 2002, Cell.

[94]  Ajit Varki,et al.  Siglecs and their roles in the immune system , 2007, Nature Reviews Immunology.

[95]  L. Aschenbrenner,et al.  Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181. , 2011, The Journal of antimicrobial chemotherapy.

[96]  M. Clerici,et al.  A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models , 2012, AIDS.

[97]  J. Goerke,et al.  Pulmonary Collectins Modulate Strain-Specific Influenza A Virus Infection and Host Responses , 2004, Journal of Virology.

[98]  J. Rodríguez-Fernández,et al.  DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents1 , 2002, The Journal of Immunology.

[99]  R. Compans,et al.  Posttranslational modification and intracellular transport of mumps virus glycoproteins , 1983, Journal of virology.

[100]  S. Swaminathan,et al.  CD209 gene polymorphisms in South Indian HIV and HIV-TB patients. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[101]  S. Gordon,et al.  Ligand recognition by antigen-presenting cell C-type lectin receptors , 2004, Current Opinion in Immunology.

[102]  G. Herrler,et al.  The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant , 1991, Journal of virology.

[103]  G. Herrler,et al.  Structural and Functional Analysis of the Surface Protein of Human Coronavirus OC43 , 1993, Virology.

[104]  R. Geyer,et al.  Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates. , 1994, Glycobiology.

[105]  Simon C Watkins,et al.  DC-SIGN on B Lymphocytes Is Required For Transmission of HIV-1 to T Lymphocytes , 2006, PLoS pathogens.

[106]  H. Nauwynck,et al.  Involvement of the Matrix Protein in Attachment of Porcine Reproductive and Respiratory Syndrome Virus to a Heparinlike Receptor on Porcine Alveolar Macrophages , 2002, Journal of Virology.

[107]  Jianpeng Ma,et al.  Crystal Structure of Unliganded Influenza B Virus Hemagglutinin , 2008, Journal of Virology.

[108]  C. Reis e Sousa,et al.  Signaling by myeloid C-type lectin receptors in immunity and homeostasis. , 2012, Annual review of immunology.

[109]  A. Dell,et al.  Endothelial Galectin-1 Binds to Specific Glycans on Nipah Virus Fusion Protein and Inhibits Maturation, Mobility, and Function to Block Syncytia Formation , 2010, PLoS pathogens.

[110]  T. Merry,et al.  Alternative approaches to antiviral treatments: focusing on glycosylation as a target for antiviral therapy , 2010, Biotechnology and applied biochemistry.

[111]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[112]  J. Jensenius,et al.  Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[113]  A. Schmitt,et al.  Paramyxovirus assembly and budding: building particles that transmit infections. , 2010, The international journal of biochemistry & cell biology.

[114]  Dennis R Burton,et al.  Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens , 2010, Proceedings of the National Academy of Sciences.

[115]  S. Gringhuis,et al.  Signalling through C-type lectin receptors: shaping immune responses , 2009, Nature Reviews Immunology.

[116]  R. Cummings,et al.  Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycans , 2006, FEBS letters.

[117]  J. Le Pendu,et al.  Mendelian resistance to human norovirus infections , 2006, Seminars in Immunology.

[118]  S. Gringhuis,et al.  HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells , 2010, Nature Immunology.

[119]  R. Yu,et al.  Structures, biosynthesis, and functions of gangliosides--an overview. , 2011, Journal of oleo science.

[120]  T. Kuiken,et al.  Assessment of the Antiviral Properties of Recombinant Porcine SP-D against Various Influenza A Viruses In Vitro , 2011, PloS one.

[121]  H. Klenk,et al.  Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding , 2003, Reviews in medical virology.

[122]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[123]  Nicole Zitzmann,et al.  α‐Glucosidase inhibitors as potential broad based anti‐viral agents , 1998, FEBS letters.

[124]  Kristen D Yetming,et al.  Murine Noroviruses Bind Glycolipid and Glycoprotein Attachment Receptors in a Strain-Dependent Manner , 2012, Journal of Virology.

[125]  S. Mercier,et al.  Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. , 2008, Virology.

[126]  D. Montefiori,et al.  Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[127]  J. Balzarini The α(1,2)‐mannosidase I inhibitor 1‐deoxymannojirimycin potentiates the antiviral activity of carbohydrate‐binding agents against wild‐type and mutant HIV‐1 strains containing glycan deletions in gp120 , 2007, FEBS Letters.

[128]  R. Johnston,et al.  Adaptation of Sindbis Virus to BHK Cells Selects for Use of Heparan Sulfate as an Attachment Receptor , 1998, Journal of Virology.

[129]  K. Hartshorn,et al.  Porcine Pulmonary Collectins Show Distinct Interactions with Influenza A Viruses: Role of the N-Linked Oligosaccharides in the Carbohydrate Recognition Domain1 , 2003, The Journal of Immunology.

[130]  R. Doms,et al.  Quantitative Expression and Virus Transmission Analysis of DC-SIGN on Monocyte-Derived Dendritic Cells , 2002, Journal of Virology.

[131]  L. Enjuanes,et al.  The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus , 2011, Virology Journal.

[132]  R. P. Aaronson,et al.  Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins , 1984, Journal of virology.

[133]  Sera,et al.  Distinct glycoprotein inhibitors of influenza A virus in different animal sera , 1991, Journal of virology.

[134]  H. Klenk,et al.  Isolation and characterization of sialate 9(4)-O-acetylesterase from influenza C virus. , 1988, Biological chemistry Hoppe-Seyler.

[135]  R. Dwek,et al.  Exploiting the defensive sugars of HIV-1 for drug and vaccine design , 2007, Nature.

[136]  S. Gringhuis,et al.  Innate signaling in HIV-1 infection of dendritic cells. , 2011, Current opinion in HIV and AIDS.

[137]  A. Pajot,et al.  Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. , 2006, Blood.

[138]  H. Ikematsu,et al.  Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza , 2011, Expert review of anti-infective therapy.

[139]  H. Klenk,et al.  The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. , 1988, The Journal of general virology.

[140]  R. Steinman,et al.  Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction1 , 2005, The Journal of Immunology.

[141]  Chih-Jen Wei,et al.  Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design , 2010, Science Translational Medicine.

[142]  G. Gaiha,et al.  Surfactant Protein A Binds to HIV and Inhibits Direct Infection of CD4+ Cells, but Enhances Dendritic Cell-Mediated Viral Transfer1 , 2008, The Journal of Immunology.

[143]  P. Colman Influenza virus neuraminidase: Structure, antibodies, and inhibitors , 1994, Protein science : a publication of the Protein Society.

[144]  Andrew G. Brooks,et al.  Specific Sites of N-Linked Glycosylation on the Hemagglutinin of H1N1 Subtype Influenza A Virus Determine Sensitivity to Inhibitors of the Innate Immune System and Virulence in Mice , 2011, The Journal of Immunology.

[145]  Xiaowu Chen,et al.  Neuraminidase Inhibitors as Anti-Influenza Virus Agents , 1999, Antiviral chemistry & chemotherapy.

[146]  H. Klenk,et al.  Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. , 2000, The Journal of general virology.

[147]  H. Tsutsumi,et al.  Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection , 2003, European journal of immunology.

[148]  S. Penadés,et al.  Multivalent Manno‐Glyconanoparticles Inhibit DC‐SIGN‐Mediated HIV‐1 Trans‐Infection of Human T Cells , 2009, Chembiochem : a European journal of chemical biology.

[149]  T. Krusat,et al.  Heparin-dependent attachment ofrespiratory syncytial virus (RSV) to host cells , 1997, Archives of Virology.

[150]  D. Eisen,et al.  Impact of mannose-binding lectin on susceptibility to infectious diseases. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[151]  A. Fauci,et al.  Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor , 2012, Proceedings of the National Academy of Sciences.

[152]  Alessio Ceroni,et al.  Characterizing the glycome of the mammalian immune system , 2008, Immunology and cell biology.

[153]  Gemma L. J. Fuller,et al.  DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets , 2006, Journal of Virology.

[154]  Douglas S Kwon,et al.  DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.

[155]  Marion C Lanteri,et al.  Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. , 2003, Glycobiology.

[156]  V. KewalRamani,et al.  Dendritic-cell interactions with HIV: infection and viral dissemination , 2006, Nature Reviews Immunology.

[157]  G. Herrler,et al.  Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus , 1997, Journal of virology.

[158]  K. Hartshorn,et al.  Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. , 2004, American journal of respiratory cell and molecular biology.

[159]  Sachiko Sato,et al.  Galectin-1 Acts as a Soluble Host Factor That Promotes HIV-1 Infectivity through Stabilization of Virus Attachment to Host Cells1 , 2005, The Journal of Immunology.

[160]  C. Mandl,et al.  Adaptation of Tick-Borne Encephalitis Virus to BHK-21 Cells Results in the Formation of Multiple Heparan Sulfate Binding Sites in the Envelope Protein and Attenuation In Vivo , 2001, Journal of Virology.

[161]  F. Gago,et al.  Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes , 2006, Journal of Virology.

[162]  D. Durantel Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. , 2009, Current opinion in investigational drugs.

[163]  C. Kelly,et al.  Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. , 2009, Chemistry.

[164]  R. Webster,et al.  Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera. , 1994, The Journal of general virology.

[165]  R. Kannagi,et al.  Human T-cell leukemia virus-1 encoded Tax protein transactivates alpha 1-->3 fucosyltransferase Fuc-T VII, which synthesizes sialyl Lewis X, a selectin ligand expressed on adult T-cell leukemia cells. , 1997, Biochemical and biophysical research communications.

[166]  J. Paulson,et al.  Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. , 1989, The Journal of biological chemistry.

[167]  Carolyn R. Bertozzi,et al.  The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins† , 2008, Biochemistry.

[168]  Maureen E. Taylor,et al.  Introduction to glycobiology , 2003 .

[169]  R. Baric,et al.  Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations , 2008, Immunological reviews.

[170]  Oscar A. Negrete,et al.  N-Glycans on Nipah Virus Fusion Protein Protect against Neutralization but Reduce Membrane Fusion and Viral Entry , 2006, Journal of Virology.

[171]  C. Mervis,et al.  Rearrangements of the Williams–Beuren syndrome locus: molecular basis and implications for speech and language development , 2007, Expert Reviews in Molecular Medicine.

[172]  R. Doms,et al.  DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency Virus , 2001, Journal of Virology.

[173]  F. Hayden,et al.  Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection , 2006, Antimicrobial Agents and Chemotherapy.

[174]  K. Van Laethem,et al.  Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity , 2011, Retrovirology.

[175]  H. Nauwynck,et al.  Effects of heparin on the entry of porcine reproductive and respiratory syndrome virus into alveolar macrophages. , 2001, Advances in experimental medicine and biology.

[176]  J. Reynolds,et al.  RNAi-directed inhibition of DC-SIGN by dendritic cells: Prospects for HIV-1 therapy , 2005, The AAPS Journal.

[177]  Y. Kawaoka,et al.  Alpha 2-macroglobulin is the major neutralizing inhibitor of influenza A virus in pig serum. , 1993, Virology.

[178]  N. Klein,et al.  Mannose‐binding lectin in innate immunity: past, present and future , 2006, Tissue antigens.

[179]  Andrzej T Galecki,et al.  Prevention of influenza pneumonitis by sialic Acid-conjugated dendritic polymers. , 2002, The Journal of infectious diseases.

[180]  Raymond A. Dwek,et al.  Targeting glycosylation as a therapeutic approach , 2002, Nature Reviews Drug Discovery.

[181]  M. Hart,et al.  Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. , 2003, The Journal of general virology.

[182]  Benhur Lee,et al.  Modes of paramyxovirus fusion: a Henipavirus perspective. , 2011, Trends in microbiology.

[183]  M. Tate,et al.  Glycosylation as a target for recognition of influenza viruses by the innate immune system. , 2007, Advances in experimental medicine and biology.

[184]  Mark von Itzstein,et al.  The war against influenza: discovery and development of sialidase inhibitors. , 2007, Nature reviews. Drug discovery.

[185]  J. McCullers,et al.  Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. , 2011, American journal of respiratory and critical care medicine.

[186]  P. Reading,et al.  A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. , 1995, Biochemical and biophysical research communications.

[187]  Anavaj Sakuntabhai,et al.  A variant in the CD209 promoter is associated with severity of dengue disease , 2005, Nature Genetics.

[188]  T. Fujita Evolution of the lectin–complement pathway and its role in innate immunity , 2002, Nature Reviews Immunology.

[189]  J. Skehel,et al.  Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus , 1998, Nature.

[190]  H. Bokhari,et al.  Selection of predicted siRNA as potential antiviral therapeutic agent against influenza virus , 2011, Bioinformation.

[191]  V. Huber,et al.  Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays , 2011, Influenza and other respiratory viruses.

[192]  L. Stamatatos,et al.  Resistance of Human Immunodeficiency Virus Type 1 to the High-Mannose Binding Agents Cyanovirin N and Concanavalin A , 2005, Journal of Virology.

[193]  V. Hascall,et al.  Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. , 1993, AIDS research and human retroviruses.

[194]  M. Hulst,et al.  Passage of Classical Swine Fever Virus in Cultured Swine Kidney Cells Selects Virus Variants That Bind to Heparan Sulfate due to a Single Amino Acid Change in Envelope Protein Erns , 2000, Journal of Virology.

[195]  B. Shaanan,et al.  Lectin-carbohydrate interactions: different folds, common recognition principles. , 1997, Trends in biochemical sciences.

[196]  Alessandra Cambi,et al.  Dual function of C-type lectin-like receptors in the immune system. , 2003, Current opinion in cell biology.

[197]  K. Hartshorn,et al.  Human mannose-binding protein functions as an opsonin for influenza A viruses. , 1993, The Journal of clinical investigation.

[198]  R. Geyer,et al.  Host-cell-specific glycosylation of HIV-2 envelope glycoprotein , 1997, Glycoconjugate Journal.

[199]  Chi-Huey Wong,et al.  Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN , 2008, Proceedings of the National Academy of Sciences.

[200]  Hiroki Inoue,et al.  Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. , 2010, Journal of medicinal chemistry.

[201]  H. Klenk,et al.  Structure and Function of the Hef Glycoprotein of Influenza C Virus , 1991, Advances in Virus Research.

[202]  D. Burton,et al.  The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade , 2011, PloS one.

[203]  H. Klenk,et al.  Neuraminic acid is involved in the binding of influenza C virus to erythrocytes. , 1985, Virology.

[204]  T. Geijtenbeek,et al.  Viral piracy: HIV-1 targets dendritic cells for transmission. , 2006, Current HIV research.

[205]  G. McFadden,et al.  The complete genome sequence of shope (rabbit) fibroma virus. , 1999, Virology.

[206]  Jianzhu Chen,et al.  Use of siRNAs to prevent and treat influenza virus infection. , 2004, Virus research.

[207]  Morgan A Reuter,et al.  HIV Traffics through a Specialized, Surface-Accessible Intracellular Compartment during trans-Infection of T Cells by Mature Dendritic Cells , 2008, PLoS pathogens.

[208]  M. Tremblay,et al.  Host-Soluble Galectin-1 Promotes HIV-1 Replication through a Direct Interaction with Glycans of Viral gp120 and Host CD4 , 2011, Journal of Virology.

[209]  Fang Fang,et al.  Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein , 2009, PloS one.

[210]  A. Sewell,et al.  Dendritic cells and transmission of HIV-1. , 2001, Trends in immunology.

[211]  B M Curtis,et al.  Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[212]  G. Vanham,et al.  Carbohydrate-Binding Agents Efficiently Prevent Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin (DC-SIGN)-Directed HIV-1 Transmission to T Lymphocytes , 2007, Molecular Pharmacology.

[213]  H. Nauwynck,et al.  Porcine Arterivirus Infection of Alveolar Macrophages Is Mediated by Sialic Acid on the Virus , 2004, Journal of Virology.

[214]  R. Steinman,et al.  The interaction of HIV with dendritic cells: outcomes and pathways , 2007, Trends in Immunology.

[215]  J. Le Pendu,et al.  Association between expression of the H histo-blood group antigen, alpha1,2fucosyltransferases polymorphism of wild rabbits, and sensitivity to rabbit hemorrhagic disease virus. , 2008, Glycobiology.

[216]  R. Doms,et al.  The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. , 2001, Virology.

[217]  G. Taylor,et al.  Neuraminidase inhibitors as antiviral agents. , 2005, Current drug targets. Infectious disorders.

[218]  K. Van Laethem,et al.  Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. , 2007, Virology.

[219]  Haruko Shirato Norovirus and histo-blood group antigens. , 2011, Japanese journal of infectious diseases.

[220]  R. Cross,et al.  Genetic Diversity and Histo-Blood Group Antigen Interactions of Rhesus Enteric Caliciviruses , 2010, Journal of Virology.

[221]  A. Dell,et al.  Dendritic Cell Maturation Results in Pronounced Changes in Glycan Expression Affecting Recognition by Siglecs and Galectins1 , 2007, The Journal of Immunology.

[222]  J. Münch,et al.  Platelet activation suppresses HIV-1 infection of T cells , 2013, Retrovirology.

[223]  Zhu-Nan Li,et al.  Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. , 2002, The Journal of general virology.

[224]  U. Gimsa,et al.  Two evolutionary strategies of influenza viruses to escape host non-specific inhibitors: alteration of hemagglutinin or neuraminidase specificity. , 1996, Virus research.

[225]  H. Nauwynck,et al.  Porcine Arterivirus Attachment to the Macrophage-Specific Receptor Sialoadhesin Is Dependent on the Sialic Acid-Binding Activity of the N-Terminal Immunoglobulin Domain of Sialoadhesin , 2007, Journal of Virology.

[226]  A. Stuart,et al.  Alpha2,6-linked sialic acid acts as a receptor for Feline calicivirus. , 2007, The Journal of general virology.

[227]  H. Klenk,et al.  Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics , 2000, Journal of Virology.

[228]  A. M. Hutson,et al.  Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus , 2008, Proceedings of the National Academy of Sciences.

[229]  S. Kornfeld,et al.  Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses , 1977, Journal of virology.

[230]  R. Jackson,et al.  Myxoma Virus Encodes an α2,3-Sialyltransferase That Enhances Virulence , 1999, Journal of Virology.

[231]  M. Matrosovich,et al.  Influenza viruses differ in recognition of 4-O-acetyl substitution of sialic acid receptor determinant. , 1992, Virology.

[232]  E. De Clercq,et al.  Marked Depletion of Glycosylation Sites in HIV-1 gp120 under Selection Pressure by the Mannose-Specific Plant Lectins of Hippeastrum Hybrid and Galanthus nivalis , 2005, Molecular Pharmacology.

[233]  C. Figdor,et al.  How C‐type lectins detect pathogens , 2005, Cellular microbiology.

[234]  Xi Jiang,et al.  Norovirus–host interaction: implications for disease control and prevention , 2007, Expert Reviews in Molecular Medicine.

[235]  J. Balzarini Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses? , 2007, Antiviral chemistry & chemotherapy.

[236]  M. Seidel,et al.  Mannan-binding lectin deficiency - Good news, bad news, doesn't matter? , 2012, Clinical immunology.

[237]  Jan Balzarini,et al.  Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus , 2006, Journal of Virology.

[238]  Benhur Lee,et al.  Novel Innate Immune Functions for Galectin-1: Galectin-1 Inhibits Cell Fusion by Nipah Virus Envelope Glycoproteins and Augments Dendritic Cell Secretion of Proinflammatory Cytokines1 , 2005, The Journal of Immunology.

[239]  J. Abastado,et al.  DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. , 2004, Blood.

[240]  R. Samulski,et al.  Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.

[241]  J. Balzarini Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy , 2007, Nature Reviews Microbiology.

[242]  B. Barrère,et al.  A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture , 1997, Archives of Virology.

[243]  S. Gordon,et al.  Divergent roles for C-type lectins expressed by cells of the innate immune system. , 2004, Molecular immunology.

[244]  E. Veldhuizen,et al.  The carbohydrate recognition domain of collectins , 2011, The FEBS journal.

[245]  Jesús Jiménez-Barbero,et al.  From lectin structure to functional glycomics: principles of the sugar code. , 2011, Trends in biochemical sciences.

[246]  W. Weis,et al.  Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR , 2001, Science.

[247]  D. Stuart,et al.  Shared paramyxoviral glycoprotein architecture is adapted for diverse attachment strategies , 2010, Biochemical Society transactions.

[248]  Emilio J. Gualda,et al.  The Neck Region of the C-type Lectin DC-SIGN Regulates Its Surface Spatiotemporal Organization and Virus-binding Capacity on Antigen-presenting Cells* , 2012, The Journal of Biological Chemistry.

[249]  Y. Kawaoka,et al.  Molecular Mechanisms of Serum Resistance of Human Influenza H3N2 Virus and Their Involvement in Virus Adaptation in a New Host , 1998, Journal of Virology.

[250]  Y. Kooyk,et al.  C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB , 2007 .

[251]  L. Morey,et al.  Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice , 1997, Journal of virology.

[252]  K. Hartshorn,et al.  Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. , 1994, The Journal of clinical investigation.

[253]  G. McFadden,et al.  Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase. , 2000, The Biochemical journal.

[254]  R. Doms,et al.  A Yeast Glycoprotein Shows High-Affinity Binding to the Broadly Neutralizing Human Immunodeficiency Virus Antibody 2G12 and Inhibits gp120 Interactions with 2G12 and DC-SIGN , 2009, Journal of Virology.

[255]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[256]  M. Froeyen,et al.  Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120 , 2005, Journal of Biological Chemistry.

[257]  M. Estes,et al.  Noroviruses everywhere: has something changed? , 2006, Current opinion in infectious diseases.

[258]  R. Dutch,et al.  Paramyxovirus Fusion and Entry: Multiple Paths to a Common End , 2012, Viruses.

[259]  R. Kannagi,et al.  Human T-Cell Leukemia Virus-1 Encoded Tax Protein Transactivates α1→3 Fucosyltransferase Fuc-T VII, Which Synthesizes Sialyl Lewis X, a Selectin Ligand Expressed on Adult T-Cell Leukemia Cells , 1997 .

[260]  M. Hart,et al.  High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. , 2002, AIDS research and human retroviruses.

[261]  D. Ho,et al.  Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC. , 2011, AIDS research and human retroviruses.

[262]  S. Harrison,et al.  Specificity and Affinity of Sialic Acid Binding by the Rhesus Rotavirus VP8* Core , 2002, Journal of Virology.

[263]  Kay-Hooi Khoo,et al.  Glycans on influenza hemagglutinin affect receptor binding and immune response , 2009, Proceedings of the National Academy of Sciences.

[264]  A. Bartesaghi,et al.  Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure , 2010, PLoS pathogens.

[265]  J. Whitsett,et al.  Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[266]  N. Roberts Anti-influenza drugs and neuraminidase inhibitors. , 2001, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[267]  J. Esko,et al.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.

[268]  T. Geijtenbeek,et al.  Langerin functions as an antiviral receptor on Langerhans cells , 2010, Immunology and cell biology.

[269]  H. Klenk,et al.  Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety , 1997, Journal of virology.

[270]  S. Harrison Viral membrane fusion , 2008, Nature Structural &Molecular Biology.

[271]  R. Eisenberg,et al.  Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production , 1980, Journal of virology.

[272]  R. Dwek,et al.  Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.

[273]  Nicolle H. Packer,et al.  Mucin‐type O‐glycosylation – putting the pieces together , 2010, The FEBS journal.

[274]  D. Burton,et al.  GP120: target for neutralizing HIV-1 antibodies. , 2006, Annual review of immunology.

[275]  M. Tate,et al.  Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. , 2011, Virology.

[276]  F. Osorio,et al.  Myeloid C-type lectin receptors in pathogen recognition and host defense. , 2011, Immunity.

[277]  M. Clerici,et al.  Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. , 2010, ACS chemical biology.

[278]  J. Kappes,et al.  Uterine Epithelial Cell Regulation of DC-SIGN Expression Inhibits Transmitted/Founder HIV-1 Trans Infection by Immature Dendritic Cells , 2010, PloS one.

[279]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[280]  H. Klenk,et al.  The receptor‐destroying enzyme of influenza C virus is neuraminate‐O‐acetylesterase. , 1985, The EMBO journal.

[281]  J. Paulson,et al.  Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. , 1983, Virology.

[282]  H. Nauwynck,et al.  Porcine reproductive and respiratory syndrome virus entry into the porcine macrophage. , 2010, The Journal of general virology.

[283]  Fang Fang,et al.  DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues , 2009, Antimicrobial Agents and Chemotherapy.

[284]  W. Weis Cell-surface carbohydrate recognition by animal and viral lectins. , 1997, Current opinion in structural biology.

[285]  P. Reading,et al.  Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. , 1994, The Journal of general virology.

[286]  Kimberly B. Ulett,et al.  N-Linked Glycosylation Attenuates H3N2 Influenza Viruses , 2007, Journal of Virology.

[287]  J. Goudsmit,et al.  An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. , 1994, Virology.

[288]  R. Pal,et al.  Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[289]  J. J. Batenburg,et al.  Collectins: players of the innate immune system. , 2004, European journal of biochemistry.

[290]  R. Wallis,et al.  High-Affinity Glycopolymer Binding to Human DC-SIGN and Disruption of DC-SIGN Interactions with HIV Envelope Glycoprotein , 2010, Journal of the American Chemical Society.

[291]  P. Mason,et al.  Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle , 1997, Journal of virology.

[292]  Wakamiya,et al.  Human mannan‐binding lectin inhibits the infection of influenza A virus without complement , 1999, Immunology.

[293]  Henrik Clausen,et al.  Location, location, location: new insights into O-GalNAc protein glycosylation. , 2011, Trends in cell biology.

[294]  A. Dubart-Kupperschmitt,et al.  Lentivirus degradation and DC‐SIGN expression by human platelets and megakaryocytes , 2006, Journal of thrombosis and haemostasis : JTH.

[295]  P. Bates,et al.  Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein , 2010, PLoS pathogens.

[296]  L. Aschenbrenner,et al.  DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis. , 2010, The Journal of antimicrobial chemotherapy.

[297]  Oscar A. Negrete,et al.  DC-SIGN Binds to HIV-1 Glycoprotein 120 in a Distinct but Overlapping Fashion Compared with ICAM-2 and ICAM-3* , 2004, Journal of Biological Chemistry.

[298]  B. Wahrén,et al.  Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 N306 glycan. , 2001, Vaccine.

[299]  L. Aschenbrenner,et al.  DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. , 2007, The Journal of infectious diseases.

[300]  S. Akira,et al.  Identification and functions of pattern-recognition receptors. , 2010, The Journal of allergy and clinical immunology.

[301]  E. Thiry,et al.  A multipotential beta -1,6-N-acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[302]  Michael T. McManus,et al.  RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[303]  Y. Kooyk,et al.  Langerin is a natural barrier to HIV-1 transmission by Langerhans cells , 2007, Nature Medicine.

[304]  D. Weissman,et al.  Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro , 2002, Journal of leukocyte biology.

[305]  P. Crocker,et al.  Siglecs as positive and negative regulators of the immune system. , 2008, Biochemical Society transactions.

[306]  M. McElrath,et al.  Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. , 2004, The Journal of infectious diseases.

[307]  L. Morris,et al.  The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. , 2012, Virology.

[308]  A. Telenti,et al.  Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides , 2012, PLoS biology.

[309]  U. Švajger,et al.  C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity , 2010, Cellular Signalling.

[310]  H. Klenk,et al.  Functional balance between haemagglutinin and neuraminidase in influenza virus infections , 2002, Reviews in medical virology.

[311]  P. Desprès,et al.  Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses , 2003, EMBO reports.

[312]  Jin Il Kim,et al.  N-Linked Glycosylation in the Hemagglutinin of Influenza A Viruses , 2012, Yonsei medical journal.

[313]  Houping Ni,et al.  Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR , 2003, Journal of Virology.

[314]  M. Chilosi,et al.  Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5 , 2001, Journal of Virology.

[315]  S. Crovella,et al.  Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission , 2011, Human Immunology.

[316]  Kristen D Yetming,et al.  Ganglioside-Linked Terminal Sialic Acid Moieties on Murine Macrophages Function as Attachment Receptors for Murine Noroviruses , 2009, Journal of Virology.

[317]  C. Garlanda,et al.  An integrated view of humoral innate immunity: pentraxins as a paradigm. , 2010, Annual review of immunology.

[318]  N. Haigwood,et al.  N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. , 1991, Journal of immunology.

[319]  A. Dell,et al.  Histo-Blood Group Antigens Act as Attachment Factors of Rabbit Hemorrhagic Disease Virus Infection in a Virus Strain-Dependent Manner , 2011, PLoS pathogens.

[320]  Xiaowu Chen,et al.  Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. , 2000, Current medicinal chemistry.

[321]  M. Palcic,et al.  A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors. , 2000, Glycobiology.

[322]  R. Jackson,et al.  Myxoma virus encodes an alpha2,3-sialyltransferase that enhances virulence. , 1999, Journal of virology.

[323]  J. Whitsett,et al.  Complementation of Pulmonary Abnormalities in SP-D(−/−) Mice with an SP-D/Conglutinin Fusion Protein* , 2002, The Journal of Biological Chemistry.

[324]  Yasuo Suzuki,et al.  Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. , 2005, Biological & pharmaceutical bulletin.

[325]  E. Schmidt,et al.  Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors , 2013, PloS one.

[326]  F. Zoulim,et al.  Glucosidase inhibitors as antiviral agents for hepatitis B and C. , 2007, Current opinion in investigational drugs.

[327]  J. Peter-Katalinic,et al.  Methods in enzymology: O-glycosylation of proteins. , 2005, Methods in enzymology.

[328]  B. Mahy,et al.  The Evolution and Emergence of RNA Viruses , 2010, Emerging Infectious Diseases.

[329]  R. D. de Groot Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses , 2006, Glycoconjugate Journal.

[330]  R. Lamb,et al.  Cell Surface Expression of Biologically Active Influenza C Virus HEF Glycoprotein Expressed from cDNA , 1999, Journal of Virology.

[331]  É. Cohen,et al.  Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother-To-Child Transmission , 2012, PloS one.

[332]  D. Duksin,et al.  Antiviral activity of tunicamycin on herpes simplex virus , 1980, Antimicrobial Agents and Chemotherapy.

[333]  Barbara Imperiali,et al.  Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems. , 2006, Glycobiology.

[334]  Kuender D Yang,et al.  DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation , 2011, PLoS neglected tropical diseases.

[335]  K. Hartshorn,et al.  Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells , 2007, Medical Microbiology and Immunology.

[336]  C. F. Brewer,et al.  Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. , 2010, Glycobiology.

[337]  Carolyn R. Bertozzi,et al.  Essentials of Glycobiology , 1999 .

[338]  M. Saleem,et al.  DC-specific ICAM-3-grabbing nonintegrin mediates internalization of HIV-1 into human podocytes. , 2010, American journal of physiology. Renal physiology.

[339]  Benhur Lee,et al.  Human Immunodeficiency Virus Envelope (gp120) Binding to DC-SIGN and Primary Dendritic Cells Is Carbohydrate Dependent but Does Not Involve 2G12 or Cyanovirin Binding Sites: Implications for Structural Analyses of gp120-DC-SIGN Binding , 2002, Journal of Virology.

[340]  M. Nacht,et al.  The influenza C virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities. , 1987, Virology.